Chronic myeloid leukemia is a slow-growing cancer of the blood-forming cells in the bone marrow, characterized by an overproduction of white blood cells and a specific genetic mutation called the Philadelphia chromosome.
Hyperbaric oxygen therapy may potentially enhance the effectiveness of traditional treatments for chronic myeloid leukemia by promoting oxygenation and improving cellular functions.